The Association Between BMI, Depression, and Post-Acute Sequelae of COVID-19 (PASC) among Nurses in Lamongan, Indonesia

Main Article Content

Abdul Rokhman
Nur Hidayati Madzkur
Faizul Hasan
Nurul Chayatin
Corresponding Author:
Nur Hidayati Madzkur | deyyacutez@gmail.com



Abstract

Introduction: Most nurses who were infected by COVID-19 experienced Post-acute Sequelae of COVID-19. Post-acute Sequelae of COVID-19 has caused fatigue, shortness of breath, memory impairment, and joint pain which make nurses unable to work optimally.  Objective: This research aimed to analyze the association between BMI, depression, and post-acute sequelae of COVID-19 among nurses in Lamongan, Indonesia.


Methods: This was a cross-sectional research which involved all nurses in Lamongan who were infected by COVID-19. The samples were obtained by purposive sampling from June to July 2022. The data were gathered by using questionnaires. Depression was measured by PHQ-9 questionnaire to which then analyzed by logistic regression test (α≤0.05).


Results: A total of 226 nurses who were infected by COVID-19 participated in this study. From the number, 45.1% were males and 54.9% were females. 96% were working in the health services while 4% were working in the educational institutions. 17.6% had history of diseases while 82.4% had no history of diseases. The results indicated that gender was not associated with both sequelae of cough and fatigue (p>0.05). BMI was not associated with either sequelae of cough or fatigue (p>0.05). Depression did not affect sequelae of cough (p=0.62), but nurses who experienced depression were 0.12 times at risk of experiencing fatigue (p=0.02).


Conclusion: It can be concluded that depression is a factor which increases fatigue.

Article Details

How to Cite
[1]
A. Rokhman, N. H. Madzkur, F. Hasan, and N. Chayatin, “The Association Between BMI, Depression, and Post-Acute Sequelae of COVID-19 (PASC) among Nurses in Lamongan, Indonesia”, Babali Nurs. Res., vol. 3, no. 3, pp. 254-263, Nov. 2022.
Section
Original Research

References

[1] WHO, “WHO Coronavirus (COVID-19) Dashboard,” Public Health and Social Measures data, 2022. .

[2] I. M. D. P. Susila and I. A. A. Laksmi, “Prevalence and Associated Factors of Burnout Risk among Emergency Nurses during COVID-19 Pandemic,” Babali Nurs. Res., vol. 3, no. 1, pp. 7–14, 2022.

[3] T. Singhal, “Review on COVID19 disease,” Indian J. Pediatr., vol. 87, no. April, pp. 281–286, 2020.

[4] G. T. Flaherty et al., “COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: A critical literature review with clinical recommendations,” Trop. Dis. Travel Med. Vaccines, vol. 6, no. 1, pp. 1–13, 2020, doi: 10.1186/s40794-020-00118-y.

[5] Y. Aungsuroch, I. G. Juanamasta, and J. Gunawan, “Experiences of Patients with Coronavirus in the COVID-19 Pandemic Era in Indonesia,” Asian J. Public Opin. Res., vol. 8, no. 3, pp. 377–392, 2020.

[6] H. I. Suhariati and I. Nofalia, “The Relationship of Mother’s Knowledge with the Selection of Educational Game Tools among Preschool Age Children during the COVID-19 Pandemic,” Babali Nurs. Res., vol. 3, no. 1, pp. 15–22, Mar. 2022, doi: 10.37363/bnr.2022.3174.

[7] M. S. Petersen et al., “Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients,” Clin. Infect. Dis., vol. 73, no. 11, pp. e4058–e4063, Dec. 2021, doi: 10.1093/cid/ciaa1792.

[8] A. Carfì, R. Bernabei, F. Landi, and for the G. A. C.-19 P.-A. C. S. Group, “Persistent symptoms in patients after acute COVID-19,” JAMA, vol. 324, no. 6, pp. 603–605, Aug. 2020, doi: 10.1001/jama.2020.12603.

[9] S. Lopez-Leon et al., “More than 50 long-term effects of COVID-19: a systematic review and meta-analysis,” Sci. Rep., vol. 11, no. 1, p. 16144, 2021, doi: 10.1038/s41598-021-95565-8.

[10] S. Compagno et al., “Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological - based rehabilitation program,” IJC Hear. Vasc., vol. 41, no. July, p. 101080, 2022, doi: 10.1016/j.ijcha.2022.101080.

[11] C. Fernández-de-las-Peñas et al., “Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis,” Eur. J. Intern. Med., vol. 92, pp. 55–70, 2021, doi: https://doi.org/10.1016/j.ejim.2021.06.009.

[12] C. H. Sudre et al., “Attributes and predictors of long COVID,” Nat. Med., vol. 27, no. 4, pp. 626–631, 2021, doi: 10.1038/s41591-021-01292-y.

[13] O. Moreno-Pérez et al., “Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study,” J. Infect., vol. 82, no. 3, pp. 378–383, 2021, doi: https://doi.org/10.1016/j.jinf.2021.01.004.

[14] C. Huang et al., “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,” Lancet, vol. 397, no. 10270, pp. 220–232, 2021, doi: https://doi.org/10.1016/S0140-6736(20)32656-8.

[15] M. Taquet, J. R. Geddes, M. Husain, S. Luciano, and P. J. Harrison, “6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,” The Lancet Psychiatry, vol. 8, no. 5, pp. 416–427, 2021, doi: https://doi.org/10.1016/S2215-0366(21)00084-5.

[16] E. Garrigues et al., “Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.,” The Journal of infection, vol. 81, no. 6. pp. e4–e6, Dec. 2020, doi: 10.1016/j.jinf.2020.08.029.

[17] T. Greenhalgh, M. Knight, C. A’Court, M. Buxton, and L. Husain, “Management of post-acute covid-19 in primary care,” BMJ, vol. 370, 2020, doi: 10.1136/bmj.m3026.

[18] A. W. Wong, A. S. Shah, J. C. Johnston, C. Carlsten, and C. J. Ryerson, “Patient-reported outcome measures after COVID-19: a prospective cohort study.,” The European respiratory journal, vol. 56, no. 5. Nov. 2020, doi: 10.1183/13993003.03276-2020.

[19] Y. M. J. Goërtz et al., “Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?,” ERJ open Res., vol. 6, no. 4, Oct. 2020, doi: 10.1183/23120541.00542-2020.

[20] J. N. Siegelman, “Reflections of a COVID-19 Long Hauler,” JAMA - J. Am. Med. Assoc., vol. 324, no. 20, pp. 2031–2032, 2020, doi: 10.1001/jama.2020.22130.

[21] D. Indriyani, I. G. Juanamasta, F. P. Indah, Hartika, and A. Budi, “The Influence of Empowerment and Compensation Towards The Work Productivity of Nurse and Midwife in The Faisal Islamic Hospital of Makassar,” Int. J. Psychosoc. Rehabil., vol. 24, no. 4, pp. 5616–5623, Feb. 2020, doi: 10.37200/IJPR/V24I4/PR201656.

[22] T. Arini and I. G. Juanamasta, “The Role of Hospital Management to Enhance Nursing Job Satisfaction,” Indones. Nurs. J. Educ. Clin., vol. 5, no. 1, pp. 82–86, 2020, doi: http://dx.doi.org/10.24990/injec.v5i1.295.

[23] K. Kroenke, R. L. Spitzer, and J. B. Williams, “The PHQ-9: validity of a brief depression severity measure.,” J. Gen. Intern. Med., vol. 16, no. 9, pp. 606–613, Sep. 2001, doi: 10.1046/j.1525-1497.2001.016009606.x.

[24] F. Instructor, K. Cox, F. Liaison, and C. Goodemann, “Caylin Cedergren , LSW , MSW Student,” pp. 9–10, 2012.

[25] M. Udedi, A. S. Muula, R. C. Stewart, and B. W. Pence, “The validity of the patient health Questionnaire-9 to screen for depression in patients with type-2 diabetes mellitus in non-communicable diseases clinics in Malawi,” BMC Psychiatry, vol. 19, no. 1, pp. 1–7, 2019, doi: 10.1186/s12888-019-2062-2.

[26] N. Fatimah, “Perbedaan Antara Obesitas Dan Non Obesitas Terhadap Kejadian Depresi Pada Ibu Rumah Tangga Di Daerah Kelurahan Cililitan, Jakarta Timur,” Fak. Kedokt. UIN Jakarta, pp. 1–56, 2014.

[27] O. Mehanna, A. El Askary, E. Ali, B. El Esawy, T. Fathalla, and A. F. Gharib, “Impact of obesity and its associated comorbid conditions on COVID-19 presentation,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. 14, pp. 409–415, 2021, doi: 10.2147/DMSO.S287779.

[28] M. A. Ingersoll, “Sex differences shape the response to infectious diseases,” Plos Pahogens, vol. 13, no. 12, 2017.

[29] S. Liu, Y. Cao, T. Du, and Y. Zhi, “Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis,” J. Allergy Clin. Immunol. Pract., vol. 9, no. 2, pp. 693–701, 2021, doi: 10.1016/j.jaip.2020.11.054.

[30] S. C. Lee, K. J. Son, C. H. Han, J. Y. Jung, and S. C. Park, “Impact of comorbid asthma on severity of coronavirus disease (COVID-19),” Sci. Rep., vol. 10, no. 1, pp. 1–9, 2020, doi: 10.1038/s41598-020-77791-8.

[31] H. Liu, S. Chen, M. Liu, H. Nie, and H. Lu, “Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: A systematic review and meta-analysis,” Aging Dis., vol. 11, no. 3, pp. 668–678, 2020, doi: 10.14336/AD.2020.0502.

[32] X. Wang et al., “Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis.,” Res. (Washington, D.C.), vol. 2020, p. 2402961, 2020, doi: 10.34133/2020/2402961.

[33] M. Alshekaili et al., “Factors associated with mental health outcomes across healthcare settings in Oman during COVID-19: Frontline versus non-frontline healthcare workers,” BMJ Open, vol. 10, no. 10, pp. 1–8, 2020, doi: 10.1136/bmjopen-2020-042030.

[34] A. Sahebi, B. Nejati-Zarnaqi, S. Moayedi, K. Yousefi, M. Torres, and M. Golitaleb, “The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses,” Prog. Neuro-Psychopharmacology Biol. Psychiatry, vol. 107, no. January, p. 110247, 2021, doi: 10.1016/j.pnpbp.2021.110247.

[35] K. T. Hurst et al., “The mental health impact of contact with COVID-19 patients on healthcare workers in the United States,” Psychiatry Res., vol. 308, no. December 2021, p. 114359, 2022, doi: 10.1016/j.psychres.2021.114359.

[36] C. H. Lee and F. Giuliani, “The Role of Inflammation in Depression and Fatigue,” Front. Immunol., vol. 10, no. July, p. 1696, 2019, doi: 10.3389/fimmu.2019.01696.